Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes

Inclusion Criteria: * Type 2 diabetes * Insulin treatment with any insulin preparation/regimen for at least three months with or without combination with below or equal to 2 oral antidiabetic agents (OADs) * Duration of diabetes at least 12 months * Body Mass Index (BMI) below 33 kg/m\^2 * HbA1c maximum 10 % based on analysis from the central laboratory Exclusion Criteria: * Current treatment with insulin above 1.2 U/kg/day * Current treatment with drugs known to interfere with glucose metabolism other than OADs such as systemic corticosteroids, non-selective beta-blockers, and monoamino oxidase (MAO) inhibitors * Blood donation of more than 500 mL within the last three months